LONDON (Reuters) -U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory in North America as early as May last year, according to the report obtained by ...
WNB Factory was cited for improper storage, inadequate holding temperature, and unlabeled food items.
LONDON, Sept 20 (Reuters) - U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's NOVOb.CO main factory in North America as early as May last year, according to the ...